Variability in commercial ginseng products: An analysis of 25 preparations

M. R. Harkey, G. L. Henderson, M. Eric Gershwin, J. S. Stern, R. M. Hackman

Research output: Contribution to journalArticle

236 Citations (Scopus)

Abstract

Background: Because dietary supplements are not subject to the same regulations that pharmaceuticals are, there is concern among medical professionals that these products may lack purity or potency. Objective: To determine the variability in a range of ginseng herbal products available in the United States, we identified and measured the concentration of marker compounds by using HPLC and liquid chromatography-tandem mass spectrometry. Design: Twenty-five commercial ginseng preparations from the genera Panax or Eleutherococcus were obtained from a local health food store and analyzed for 7 ginsenosides (marker compounds for Panax species, which include Asian and American ginseng) and 2 eleutherosides (marker compounds for Eleutherococcus senticosus, also known as Siberian ginseng). Results: All plant products were correctly identified by botanical plant species (ie, Panax species or E. senticosus); however, concentrations of marker compounds differed significantly from labeled amounts. There was also significant product-to-product variability: concentrations of ginsenosides varied by 15- and 36-fold in capsules and liquids, respectively, and concentrations of eleutherosides varied by 43- and 200-fold in capsules and liquids, respectively. Although a systematic search for adulterants was not conducted, review of the HPLC and liquid chromatography-tandem mass spectrometry data suggest that no substances other than ginsenosides or eleutherosides were extracted from the plant material. Conclusion: Our data suggest that US ginseng products are correctly labeled as to plant genus; however, variability in concentrations of marker compounds suggests that standardization may be necessary for quality assurance and that characterization of herbal products should be considered in the design and evaluation of studies on herbal products.

Original languageEnglish (US)
Pages (from-to)1101-1106
Number of pages6
JournalAmerican Journal of Clinical Nutrition
Volume73
Issue number6
StatePublished - 2001

Fingerprint

Panax
Eleutherococcus
Eleutherococcus senticosus
Ginsenosides
liquid chromatography
Tandem Mass Spectrometry
Liquid Chromatography
high performance liquid chromatography
Capsules
Panax quinquefolius
High Pressure Liquid Chromatography
Panax ginseng
health foods
food storage
liquids
plant products
adulterated products
health care workers
Asian Americans
standardization

Keywords

  • Dietary supplements
  • Eleutherococcus
  • Eleutherosides
  • Ginseng
  • Ginsenosides
  • Panax
  • Quality assurance
  • Standardization

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Food Science

Cite this

Harkey, M. R., Henderson, G. L., Gershwin, M. E., Stern, J. S., & Hackman, R. M. (2001). Variability in commercial ginseng products: An analysis of 25 preparations. American Journal of Clinical Nutrition, 73(6), 1101-1106.

Variability in commercial ginseng products : An analysis of 25 preparations. / Harkey, M. R.; Henderson, G. L.; Gershwin, M. Eric; Stern, J. S.; Hackman, R. M.

In: American Journal of Clinical Nutrition, Vol. 73, No. 6, 2001, p. 1101-1106.

Research output: Contribution to journalArticle

Harkey, MR, Henderson, GL, Gershwin, ME, Stern, JS & Hackman, RM 2001, 'Variability in commercial ginseng products: An analysis of 25 preparations', American Journal of Clinical Nutrition, vol. 73, no. 6, pp. 1101-1106.
Harkey, M. R. ; Henderson, G. L. ; Gershwin, M. Eric ; Stern, J. S. ; Hackman, R. M. / Variability in commercial ginseng products : An analysis of 25 preparations. In: American Journal of Clinical Nutrition. 2001 ; Vol. 73, No. 6. pp. 1101-1106.
@article{aacddd440d6146ce8644c62088586af6,
title = "Variability in commercial ginseng products: An analysis of 25 preparations",
abstract = "Background: Because dietary supplements are not subject to the same regulations that pharmaceuticals are, there is concern among medical professionals that these products may lack purity or potency. Objective: To determine the variability in a range of ginseng herbal products available in the United States, we identified and measured the concentration of marker compounds by using HPLC and liquid chromatography-tandem mass spectrometry. Design: Twenty-five commercial ginseng preparations from the genera Panax or Eleutherococcus were obtained from a local health food store and analyzed for 7 ginsenosides (marker compounds for Panax species, which include Asian and American ginseng) and 2 eleutherosides (marker compounds for Eleutherococcus senticosus, also known as Siberian ginseng). Results: All plant products were correctly identified by botanical plant species (ie, Panax species or E. senticosus); however, concentrations of marker compounds differed significantly from labeled amounts. There was also significant product-to-product variability: concentrations of ginsenosides varied by 15- and 36-fold in capsules and liquids, respectively, and concentrations of eleutherosides varied by 43- and 200-fold in capsules and liquids, respectively. Although a systematic search for adulterants was not conducted, review of the HPLC and liquid chromatography-tandem mass spectrometry data suggest that no substances other than ginsenosides or eleutherosides were extracted from the plant material. Conclusion: Our data suggest that US ginseng products are correctly labeled as to plant genus; however, variability in concentrations of marker compounds suggests that standardization may be necessary for quality assurance and that characterization of herbal products should be considered in the design and evaluation of studies on herbal products.",
keywords = "Dietary supplements, Eleutherococcus, Eleutherosides, Ginseng, Ginsenosides, Panax, Quality assurance, Standardization",
author = "Harkey, {M. R.} and Henderson, {G. L.} and Gershwin, {M. Eric} and Stern, {J. S.} and Hackman, {R. M.}",
year = "2001",
language = "English (US)",
volume = "73",
pages = "1101--1106",
journal = "American Journal of Clinical Nutrition",
issn = "0002-9165",
publisher = "American Society for Nutrition",
number = "6",

}

TY - JOUR

T1 - Variability in commercial ginseng products

T2 - An analysis of 25 preparations

AU - Harkey, M. R.

AU - Henderson, G. L.

AU - Gershwin, M. Eric

AU - Stern, J. S.

AU - Hackman, R. M.

PY - 2001

Y1 - 2001

N2 - Background: Because dietary supplements are not subject to the same regulations that pharmaceuticals are, there is concern among medical professionals that these products may lack purity or potency. Objective: To determine the variability in a range of ginseng herbal products available in the United States, we identified and measured the concentration of marker compounds by using HPLC and liquid chromatography-tandem mass spectrometry. Design: Twenty-five commercial ginseng preparations from the genera Panax or Eleutherococcus were obtained from a local health food store and analyzed for 7 ginsenosides (marker compounds for Panax species, which include Asian and American ginseng) and 2 eleutherosides (marker compounds for Eleutherococcus senticosus, also known as Siberian ginseng). Results: All plant products were correctly identified by botanical plant species (ie, Panax species or E. senticosus); however, concentrations of marker compounds differed significantly from labeled amounts. There was also significant product-to-product variability: concentrations of ginsenosides varied by 15- and 36-fold in capsules and liquids, respectively, and concentrations of eleutherosides varied by 43- and 200-fold in capsules and liquids, respectively. Although a systematic search for adulterants was not conducted, review of the HPLC and liquid chromatography-tandem mass spectrometry data suggest that no substances other than ginsenosides or eleutherosides were extracted from the plant material. Conclusion: Our data suggest that US ginseng products are correctly labeled as to plant genus; however, variability in concentrations of marker compounds suggests that standardization may be necessary for quality assurance and that characterization of herbal products should be considered in the design and evaluation of studies on herbal products.

AB - Background: Because dietary supplements are not subject to the same regulations that pharmaceuticals are, there is concern among medical professionals that these products may lack purity or potency. Objective: To determine the variability in a range of ginseng herbal products available in the United States, we identified and measured the concentration of marker compounds by using HPLC and liquid chromatography-tandem mass spectrometry. Design: Twenty-five commercial ginseng preparations from the genera Panax or Eleutherococcus were obtained from a local health food store and analyzed for 7 ginsenosides (marker compounds for Panax species, which include Asian and American ginseng) and 2 eleutherosides (marker compounds for Eleutherococcus senticosus, also known as Siberian ginseng). Results: All plant products were correctly identified by botanical plant species (ie, Panax species or E. senticosus); however, concentrations of marker compounds differed significantly from labeled amounts. There was also significant product-to-product variability: concentrations of ginsenosides varied by 15- and 36-fold in capsules and liquids, respectively, and concentrations of eleutherosides varied by 43- and 200-fold in capsules and liquids, respectively. Although a systematic search for adulterants was not conducted, review of the HPLC and liquid chromatography-tandem mass spectrometry data suggest that no substances other than ginsenosides or eleutherosides were extracted from the plant material. Conclusion: Our data suggest that US ginseng products are correctly labeled as to plant genus; however, variability in concentrations of marker compounds suggests that standardization may be necessary for quality assurance and that characterization of herbal products should be considered in the design and evaluation of studies on herbal products.

KW - Dietary supplements

KW - Eleutherococcus

KW - Eleutherosides

KW - Ginseng

KW - Ginsenosides

KW - Panax

KW - Quality assurance

KW - Standardization

UR - http://www.scopus.com/inward/record.url?scp=0034982633&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034982633&partnerID=8YFLogxK

M3 - Article

C2 - 11382666

AN - SCOPUS:0034982633

VL - 73

SP - 1101

EP - 1106

JO - American Journal of Clinical Nutrition

JF - American Journal of Clinical Nutrition

SN - 0002-9165

IS - 6

ER -